Concepedia

Thomas Schmelter

TS

Statistics

Publications

39

Citations

3.8K

H-Index

24

Active since

2002

Affiliations

Bayer (Germany)(Current)

Regeneron (United States)

Bayer (Switzerland)

Retina Consultants of Texas

Ophthalmic Consultants of Boston

Thomas Schmelter is an author at Bayer (Germany) specializing in medicine, ophthalmology, and diabetic retinopathy.

ORCID

Top concepts

Publications per year

2002–2024

39

Publications

39

Intravitreal Aflibercept for Diabetic Macular Edema

Jean‐François Korobelnik, V. Diana, Ursula Schmidt‐Erfurth et al. · Ophthalmology · 2014 · 785 citations · Full text

, , +2

Intravitreal Aflibercept for Diabetic Macular Edema

David M. Brown, Ursula Schmidt‐Erfurth, V. Diana et al. · Ophthalmology · 2015 · 602 citations

, , +2

Intravitreal Aflibercept for Diabetic Macular Edema

Jeffrey S. Heier, Jean‐François Korobelnik, David M. Brown et al. · Ophthalmology · 2016 · 404 citations

, , +2

One-Year Outcomes of the DA VINCI Study of VEGF Trap-Eye in Eyes with Diabetic Macular Edema

V. Diana, Quan Dong Nguyen, David S. Boyer et al. · Ophthalmology · 2012 · 390 citations

, , +7

Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial

Paolo Lanzetta, Jean‐François Korobelnik, Jeffrey S. Heier et al. · The Lancet · 2024 · 179 citations

, , +5

1–5 of 39